AFFINITYSCAN Trademark

Trademark Overview


On Wednesday, July 13, 2022, a trademark application was filed for AFFINITYSCAN with the United States Patent and Trademark Office. The USPTO has given the AFFINITYSCAN trademark a serial number of 97501427. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, August 21, 2023. This trademark is owned by EUROFINS DISCOVERX CORPORATION. The AFFINITYSCAN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Scientific and technological services, namely, drug discovery and development services, research discovery and development services, pharmaceuticals research services in the field of biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Scientific research; Scientific research and development; Scientific research consulting; Scientific research consulting in the field of drug discovery and development, research discovery and development in biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Scientific study and research in the field(s) of research discovery and development in biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical...
affinityscan

General Information


Serial Number97501427
Word MarkAFFINITYSCAN
Filing DateWednesday, July 13, 2022
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, August 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkAFFINITY SCAN
Goods and ServicesPharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Scientific and technological services, namely, drug discovery and development services, research discovery and development services, pharmaceuticals research services in the field of biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Scientific research; Scientific research and development; Scientific research consulting; Scientific research consulting in the field of drug discovery and development, research discovery and development in biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Scientific study and research in the field(s) of research discovery and development in biotechnology, pharmaceuticals, diagnostics, medical therapy, and biopharmaceuticals; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Providing scientific information in the field of drug discovery services, scientific and technological services, pharma research services for research and development in biotechnology, pharmaceuticals, diagnostics, medical therapy, and bipharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 2, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEUROFINS DISCOVERX CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92121

Trademark Events


Event DateEvent Description
Wednesday, February 21, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Monday, August 21, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, August 21, 2023LETTER OF SUSPENSION E-MAILED
Monday, August 21, 2023SUSPENSION LETTER WRITTEN
Friday, July 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 18, 2023NON-FINAL ACTION E-MAILED
Thursday, May 18, 2023NON-FINAL ACTION WRITTEN
Thursday, April 27, 2023ASSIGNED TO EXAMINER
Tuesday, August 2, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 16, 2022NEW APPLICATION ENTERED